Experiments demonstrate butylhydroxytoluene reduces dna damage and increases lifespan in drosophila, suggesting its potential as a radioprotective agent.
In experiments on Drosophila melanogaster, the radiomodifying effect of butylhydroxytoluene (BHT) was assessed by studying the level of DNA damage and lifespan in the wild-type Canton-S strain and sod-gene mutants. It was found that the introduction of BHT into the diet of Drosophila can lead to a decrease in sensitivity to chronic γ-radiation of different intensities (0.42 and 40.3 mGy/h). In individuals with normal gene functioning (Canton-S), which develop under conditions of chronic irradiation, BHT in concentrations above 1 μM has a beneficial effect on the cytogenetic index (reducing its level at dose rates of 0.42 and 40.3 mGy/h) and lifespan (increasing its parameters at dose rate of 0.42 mGy/h). A specific effect of BHT on genotypes with low activity of cytoplasmic (sod[n1]/+) and mitochondrial (sod[delta02]/+) superoxide dismutase was found. According to the "DNA damage" and "survival" parameters, the most pronounced radioprotective effect of BHT was noted in animals of the sod[n1]/+ strain. This effect was recorded at concentrations of the substance exceeding 10 μM and at all irradiation rates. In individuals of the sod[delta02]/+ strain, the antiradiation effect of BHT was revealed at concentrations of 10-20 μM (on the level of DNA damage) and 100 μM (on lifespan). The combination of BHT and chronic irradiation has a predominantly antagonistic (in all genotypes), less often synergistic/additive (in sod-mutants) character. This preparation, depending on the concentration, is able to reduce DNA damage and increase the lifespan of individuals of a certain genotype, which indicates its ability to slow down the aging process. Thus, the experimental data indicate that the introduction of BHT into the diet of Drosophila can have a radioprotective effect, adapting the organism to chronic γ-radiation. The efficiency of this effect depends on the genetic background of animals, especially on the activity level of the corresponding sod-genes.
No takes yet. Share an insight, caveat, or question.
Yushkova E (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: